Development and validation of a comprehensive genomic diagnostic tool for myeloid malignancies. (2016)
Attributed to:
Characterising and targeting aberrant enhancer function in acute myeloid leukaemia (AML)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1182/blood-2015-11-683334
PubMed Identifier: 27121471
Publication URI: http://europepmc.org/abstract/MED/27121471
Type: Journal Article/Review
Volume: 128
Parent Publication: Blood
Issue: 1
ISSN: 0006-4971